S&P 500   4,551.68
DOW   35,490.69
QQQ   380.00
S&P 500   4,551.68
DOW   35,490.69
QQQ   380.00
S&P 500   4,551.68
DOW   35,490.69
QQQ   380.00
S&P 500   4,551.68
DOW   35,490.69
QQQ   380.00

iBio Insider Trades

-0.02 (-2.56 %)
(As of 10/27/2021 12:00 AM ET)
Today's Range
50-Day Range
52-Week Range
2.67 million shs
Average Volume
8.85 million shs
Market Capitalization
$165.82 million
P/E Ratio
Dividend Yield

iBio (NYSEAMERICAN:IBIO) Insider Buying and Selling Activity

1.00% of iBio's shares are owned by company executives, directors and other insiders.
Skip Chart & View Insider Trade History

Insider Buying and Selling by Quarter

iBio (NYSEAMERICAN IBIO) Insider Trading History

Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
8/11/2020Eastern Capital LtdMajor ShareholderSell24,484,904$3.27$80,065,636.08
8/6/2020Eastern Capital LtdMajor ShareholderSell2,768,137$4.18$11,570,812.6636,782,734  
8/4/2020Eastern Capital LtdMajor ShareholderSell600,000$4.39$2,634,000.0036,782,734  
6/4/2020Robert L. ErwinPresidentSell28,268$1.71$48,338.28  
6/2/2020Robert L. ErwinPresidentSell96,124$1.62$155,720.88  
5/27/2020James P. MullaneyCFOSell11,250$1.61$18,112.50  
7/12/2018Eastern Capital LtdMajor ShareholderBuy2,200,000$0.90$1,980,000.008,457,734  
6/26/2018Eastern Capital LtdMajor ShareholderBuy1,683,334$0.90$1,515,000.606,257,734  
11/30/2017Eastern Capital LtdMajor ShareholderBuy12,000,000$0.20$2,400,000.0045,744,000  
4/7/2016Eastern Capital LtdMajor ShareholderBuy6,500,000$0.62$4,030,000.0033,744,000  
1/25/2016Eastern Capital Ltdmajor shareholderBuy3,500,000$0.62$2,170,000.0027,244,000  
9/17/2014Carl DesantisMajor ShareholderSell138,710$0.67$92,935.70  
2/3/2014Carl DesantisMajor ShareholderSell28,828$0.55$15,855.40  
1/31/2014Carl DesantisMajor ShareholderSell74,049$0.56$41,467.44  
1/29/2014Carl DesantisMajor ShareholderSell128,708$0.58$74,650.64  
8/13/2013Carl DesantisMajor ShareholderSell37,689$0.50$18,844.50  
8/8/2013Carl DesantisMajor ShareholderSell324,395$0.54$175,173.30  
8/6/2013Carl DesantisMajor ShareholderSell53,065$0.50$26,532.50  
8/2/2013Carl DesantisMajor ShareholderSell99,945$0.50$49,972.50  
7/30/2013Carl DesantisMajor ShareholderSell34,605$0.51$17,648.55  
7/26/2013Carl DesantisMajor ShareholderSell27,255$0.50$13,627.50  
7/23/2013Carl DesantisMajor ShareholderSell39,465$0.51$20,127.15  
7/19/2013Carl DesantisMajor ShareholderBuy1,732,679$0.52$900,993.08  
(Data available from 1/1/2013 forward)

iBio (NYSEAMERICAN:IBIO) Insider Trade Frequently Asked Questions

Who is on iBio's Insider Roster?

The list of insiders at iBio includes Eastern Capital Ltd, James P. Mullaney, and Robert L. Erwin.Learn more on IBIO's insiders

What percentage of iBio stock is owned by insiders?

1.00% of iBio stock is owned by insiders. Learn more on IBIO's insider holdings

Which iBio insiders have been selling company stock?

The following insiders have sold iBio stock in the last 24 months: Eastern Capital Ltd ($94,270,448.74), James P. Mullaney ($18,112.50), and Robert L. Erwin ($204,059.16).

How much insider selling is happening at iBio?

Insiders have sold a total of 27,988,683 iBio shares in the last 24 months for a total of $94,492,620.40 sold.

This page was last updated on 10/28/2021 by MarketBeat.com Staff


Premium Research Tools

MarketBeat All Access subscribers can access stock screeners, the Idea Engine, data export tools, research reports, and other premium tools.

Discover All Access

Market Data and Calendars

Looking for new stock ideas? Want to see which stocks are moving? View our full suite of financial calendars and market data tables, all for free.

View Market Data

Investing Education and Resources

Receive a free world-class investing education from MarketBeat. Learn about financial terms, types of investments, trading strategies and more.

Financial Terms
Details Here
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2021. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information

© 2021 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research.